phosphatidylcholines has been researched along with methylergonovine in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (methylergonovine) | Trials (methylergonovine) | Recent Studies (post-2010) (methylergonovine) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 527 | 44 | 70 |
Protein | Taxonomy | phosphatidylcholines (IC50) | methylergonovine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.013 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.59 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.2 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.829 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.461 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0041 | |
D(1A) dopamine receptor | Homo sapiens (human) | 1.077 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.013 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0041 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.167 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0015 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.0025 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tomasević, M; Zulić, S | 1 |
1 other study(ies) available for phosphatidylcholines and methylergonovine
Article | Year |
---|---|
[Lipostabil forte in the control of hyperlipidemia in diabetics].
Topics: Diabetes Complications; Female; Humans; Hyperlipidemias; Lipids; Male; Methylergonovine; Middle Aged; Phosphatidylcholines | 1984 |